Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Aloud Real-time Reading of ICU Diaries for Prevention of Negative Post-ICU Psychological Outcomes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04510272
Recruitment Status : Completed
First Posted : August 12, 2020
Last Update Posted : April 27, 2021
Sponsor:
Information provided by (Responsible Party):
Lioudmila Karnatovskaia, Mayo Clinic

Brief Summary:
This study will evaluate whether a systematically delivered, patient-oriented real time communication via aloud real time readings of ICU diary entries during patient's ICU stay is feasible

Condition or disease Intervention/treatment Phase
Anxiety Depression PTSD Other: Aloud Real-time Reading of ICU Diaries Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 72 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Aloud Real-time Reading of ICU Diaries for Prevention of Negative Post-ICU Psychological Outcomes: A Feasibility Study
Actual Study Start Date : September 1, 2020
Actual Primary Completion Date : March 9, 2021
Actual Study Completion Date : March 9, 2021

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: High risk critically ill patients
Critically ill patients requiring vasopressor support or mechanical ventilation will receive aloud real time ICU diary reading intervention
Other: Aloud Real-time Reading of ICU Diaries
Standard ICU diaries will be read aloud in real time daily to patients by ICU nurses/therapists/family members




Primary Outcome Measures :
  1. Number of days patients successfully receive the intervention [ Time Frame: Length of ICU admission ]
    Feasibility of the intervention as defined by ICU diary entries being read aloud on >80% of days they were entered



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • High risk critically ill patients: adults (age ≥ 18) in acute respiratory failure and/or requiring vasopressors admitted to the ICU and expected to stay >48 hours. adults (age ≥ 18) in acute respiratory failure and/or requiring vasopressors admitted to the ICU and expected to stay >48 hours
  • Enrolled patient's family members.
  • Critical care nurses.
  • Physical/Occupational therapists writing ICU diary entries.

Exclusion Criteria:

  • History of dementia, mental retardation, suicide attempt, psychotic disorders such as schizophrenia, acute alcohol/substance intoxication or withdrawal, severe metabolic encephalopathy; patients on comfort care; patients not expected to survive the hospital stay or non-English speaking

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04510272


Locations
Layout table for location information
United States, Minnesota
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905
Sponsors and Collaborators
Mayo Clinic
Investigators
Layout table for investigator information
Principal Investigator: Lioudmila V Karnatovskaia, MD Mayo Clinic
Additional Information:
Layout table for additonal information
Responsible Party: Lioudmila Karnatovskaia, Principal Investigator, Mayo Clinic
ClinicalTrials.gov Identifier: NCT04510272    
Other Study ID Numbers: 20-002275
First Posted: August 12, 2020    Key Record Dates
Last Update Posted: April 27, 2021
Last Verified: April 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Lioudmila Karnatovskaia, Mayo Clinic:
Critical illness
PTSD
Depression
anxiety
PICS
Additional relevant MeSH terms:
Layout table for MeSH terms
Depression
Behavioral Symptoms